1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Ms E Walmsley
|
|
b)
|
Position/status
|
Chief Executive Officer
|
|
c)
|
Initial
notification/ amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature of the
transaction
|
The
exercise of options over 137,040 Ordinary Shares, granted on 22
July 2010 under the GlaxoSmithKline 2009 Share Option
Plan.
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
£12.035
|
137,040
|
||
d)
|
Aggregated
information
Aggregated
volume
Price
|
N/A (single transaction)
|
|
e)
|
Date
of the transaction
|
2019-10-31
|
|
f)
|
Place of the
transaction
|
N/A
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Ms E Walmsley
|
|
b)
|
Position/status
|
Chief Executive Officer
|
|
c)
|
Initial
notification/ amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature of the
transaction
|
The
sale of 112,945 Ordinary Shares to cover the tax and cost of
exercise of the options granted on 22 July 2010 under the
GlaxoSmithKline 2009 Share Option Plan.
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
£17.7588
|
112,945
|
||
d)
|
Aggregated
information
Aggregated
volume
Price
|
N/A (single transaction)
|
|
e)
|
Date
of the transaction
|
2019-10-31
|
|
f)
|
Place of the
transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Ms E Walmsley
|
|
b)
|
Position/status
|
Chief Executive Officer
|
|
c)
|
Initial
notification/ amendment
|
Initial Notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|
b)
|
Nature of the
transaction
|
Transfer of 24,095 Ordinary Shares to spouse for nil
consideration.
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
£0.00
|
24,095
|
||
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated volume
Price
|
|
||
e)
|
Date
of the transaction
|
2019-10-31
|
|
f)
|
Place of the
transaction
|
N/A
|
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Mr David Owen
|
|
b)
|
Position/status
|
PCA of Ms E Walmsley (Chief Executive Officer)
|
|
c)
|
Initial
notification/ amendment
|
Initial Notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|
b)
|
Nature of the
transaction
|
Receipt of 24,095 Ordinary Shares from spouse for nil
consideration.
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
£0.00
|
24,095
|
||
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated volume
Price
|
|
||
e)
|
Date
of the transaction
|
2019-10-31
|
|
f)
|
Place of the
transaction
|
N/A
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: November
01, 2019
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|